Purchase Order HT942523P0030
Award Date 5/1/23
Potential Completion Date 12/29/23
Potential Value $85K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North River, ND 58102, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Genovac Antibody Discovery LLC, a self-certified small disadvantaged business, for the development and analysis of human monoclonal antibodies (mABs). The $180,000.00 contract supports the Walter Reed Army Institute of Research (WRAIR) and Armed Forces Research Institute of Medical Sciences (WRAIR-AFRIMS) programs. The contract has a base period of 1 year with two 1-year option periods and does not have a...
- This is a $356,021 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Avantgen Inc., a San Diego-based biotechnology company. The contract is for the development of rabbit monoclonal antibodies for ferret biomarkers. This work is set aside for small businesses. Avantgen has previously received NIH contracts to develop rapid diagnostic...
- The Defense Health Agency awarded a $1.43M firm fixed-price purchase order to Government Scientific Source Inc., a small business based in Reston, Virginia, for an AMBR 250 high throughput bioreactor system designated for vaccine and biologic production as well as monoclonal antibody development targeting military-relevant infectious disease threats. The contract carries a total small business set-aside designation and is scheduled for completion by March 1, 2030, with performance occurring in...
- The Defense Health Agency awarded a $1.3 million firm fixed-price purchase order to Eitr Biologics, Inc., a San Diego-based biotechnology company specializing in antibody discovery and viral countermeasures. The contract, set aside for small business, focuses on sorting peripheral blood mononuclear cells from Lassa fever virus survivors to discover and produce monoclonal antibodies for subsequent assessment in in vitro and in vivo assays. This work supports the Defense Health Agency's medical...
- The Defense Health Agency issued a $20,500 delivery order to Mapp Biopharmaceutical, Inc. on February 6, 2026, for procurement of human-derived monoclonal antibodies and antigens, with completion by April 24, 2026. The order is issued under Mapp's single-award indefinite delivery contract with the Defense Health Agency valued at $2 million for material requirement and delivery of antibody and antigen supply, with a performance period from June 1, 2025, through May 31, 2030. Place of...
- The USDA Agricultural Research Service (ARS) awarded a $53,340 firm-fixed-price purchase order to Green Mountain Antibodies Inc. on November 19, 2025, for the production of monoclonal antibodies targeting H5 highly pathogenic avian influenza (HPAI). The contract requires delivery of 4 mg of purified monoclonal antibodies—specifically 1 mg from each of two clones for each of two antigens—along with four vials of viable hybridomas. The monoclonal antibodies will be engineered to target the...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Green Mountain Antibodies Inc., a for-profit manufacturer of goods. The $10,090.00 firm-fixed-price purchase order is for the generation of MA3 rat hybridomas and production of antibodies. The work will be performed in Burlington, Vermont and has a completion date of September 17, 2015. No set-aside designation was used for this...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), for a CUSTOM ANTIBODY PROJECT. The contract was awarded to Aves Laboratories, a self-certified small disadvantaged, woman-owned, Asian-Pacific American-owned business, on March 22, 2016 with a completion date of April 21, 2016 and a ceiling value of $33,917.00. The contract does not have a set-aside...
- This federal contract award, valued at $85,340.00, was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Genedata (USA), Inc., a foreign-owned, self-certified small disadvantaged business. The contract provides for the software license, maintenance, and support of Genedata Screener, the company's proprietary bioinformatics software platform, to support critical research initiatives,...
- The Defense Health Agency awarded a $110.5 million firm fixed-price delivery order to Mapp Biopharmaceutical, Inc., a San Diego-based biotechnology company specializing in antibody-based therapeutics and medical countermeasures. The delivery order, awarded on June 6, 2025, with completion scheduled for December 4, 2025, calls for the supply of monoclonal antibodies and viral recombinant antigens. No set-aside designation was used in this award. This delivery order is issued under Mapp's...
The Defense Health Agency awarded a $84,720.53 firm fixed price purchase order to Genovac Antibody Discovery LLC, a small disadvantaged business, for the generation of monoclonal antibodies targeting ferret immunoglobulin M and immunoglobulin G. This requirement was solicited as a 100% small business set-aside. The contract has an ultimate completion date of December 29, 2023 and was awarded on May 1, 2023. The contract was issued under a federal contract opportunity posted on April 7, 2023 with a due date of April 18, 2023. This requirement supports the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).
Generated 6/26/24, 9:43 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Monoclonal Antibodies targeting the ferret immunoglobulin M and immunoglobulin G in support of USAMRIID | HT942523Q0045 | Department of the Army Medical Command | Solicitation 1/3 | 4/7/23, 3:02 PM | |
Amendment 0001 - Monoclonal Antibodies targeting the ferret immunoglobulin M and immunoglobulin G in support of USAMRIID | HT942523Q00450001 | Defense Health Agency | Special Notice 2/3 | 4/13/23, 9:26 AM | |
Monoclonal Antibodies targeting the ferret immunoglobulin M and immunoglobulin G in support of USAMRIID | HT942523P0030 | Defense Health Agency | Award Notice 3/3 | 5/3/23, 8:05 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $1.0k | 3/27/24 | |
| Not listed | Not listed | $83.7k | 4/26/23 |